Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
about
The use of lentinan for treating gastric cancerThe Medicinal Mushroom Agaricus blazei Murrill: Review of Literature and Pharmaco-Toxicological ProblemsWhich botanicals or other unconventional anticancer agents should we take to clinical trial?Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injuryHow many repeated measures in repeated measures designs? Statistical issues for comparative trialsConstruction, analysis, and beta-glucanase screening of a bacterial artificial chromosome library from the large-bowel microbiota of mice.Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production.Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastomaImmunomodulatory dietary polysaccharides: a systematic review of the literatureOrally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancerImmunomodulatory activity of dietary fiber: arabinoxylan and mixed-linked beta-glucan isolated from barley show modest activities in vitroThe effects of beta-glucan on human immune and cancer cells.GD2-targeted immunotherapy and radioimmunotherapyA phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effectsMaitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicityCombined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers.Induction of apoptosis by laminarin, regulating the insulin-like growth factor-IR signaling pathways in HT-29 human colon cellsYeast-derived beta-glucan augments the therapeutic efficacy mediated by anti-vascular endothelial growth factor monoclonal antibody in human carcinoma xenograft models.Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy.Immunostimulating properties of intragastrically administered Acetobacter-derived soluble branched (1,4)-beta-D-glucans decrease murine susceptibility to Listeria monocytogenesβ-Glucan supplementation, allergy symptoms, and quality of life in self-described ragweed allergy sufferers.Effects of glucan on bone marrow.High- and low-Molecular Weight oat Beta-Glucan Reveals Antitumor Activity in Human Epithelial Lung Cancer.Lung cancer and β-glucans: review of potential therapeutic applications.Phellinus linteus Grown on Germinated Brown Rice Increases Cetuximab Sensitivity of KRAS-Mutated Colon Cancer.Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission.Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases.
P2860
Q24619416-42378659-7485-4DD1-92B6-342540F17A03Q24644957-F1F00516-6227-49F7-95EA-5A7CD4B9C2AEQ24652544-318E4E7D-60BA-49B4-A927-10129521FA10Q24685769-C002DFEC-8DE8-4451-8B8F-289C5E8CBE02Q24797517-CDC8452D-379C-4692-A87B-73C274322EB6Q33214668-4465B2DE-F090-4808-A55A-BC93665DA3FDQ33263087-AA6AC8D4-362E-4183-A5A3-2A0B9A9B8EB6Q33408675-0B98042A-542D-474D-A79C-3715FE950EEBQ34150565-95777422-D7D9-4F05-859A-8CFB1394183BQ34267746-2DDCE6D2-A17D-4D4B-8E69-09F102E8BE09Q34578143-4B7E41E4-9096-42F7-81D1-46F5B19177FCQ34608777-9191CA06-7905-4F8F-B03D-D9B7AEADED06Q34625339-5548417F-385A-42E6-858D-5469964E454EQ34954952-57A4B96A-1B54-4FF7-8218-0F387EE3A8B6Q35710628-A5C2FAB2-E5FD-4342-8C22-BDB9FEC54982Q35914730-2418E49B-D7C1-4B37-8F65-5359EDC71192Q36347902-A2102540-9616-4118-A0DD-B8E577094205Q36613743-11E26EA9-7349-45C7-95B2-37C79ABC61C2Q36672598-497A8DE6-14C4-444D-8CAB-1E9E075F92FAQ37201291-3DE3DBDE-D5F1-4E75-B156-1EEE42C5903BQ37623657-44EE70ED-FD6A-463D-8A8B-75A4AEEF0A1DQ37633371-85830F46-0A55-4BBC-9198-22E570B2C758Q38261685-4A6D51E2-5628-45A9-A9E0-8D332BEACBD2Q38696142-656D73DF-65F6-4833-978F-8B6177FFD42DQ39183310-10246784-2E0D-49CB-B9D7-7F2AE8ABD7E9Q40086054-60F09F12-681F-4E16-AFBB-AFF25F50B2E0Q41394300-43031DE1-5C85-4B60-9EA4-59114435348AQ42705635-48FF8D23-89E8-4F1E-8C11-9F9786CF721C
P2860
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
@ast
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
@en
type
label
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
@ast
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
@en
prefLabel
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
@ast
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
@en
P2093
P1476
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
@en
P2093
Benny Knuckles
Nai-Kong V Cheung
Shakeel Modak
P2888
P304
P356
10.1007/S00262-002-0321-3
P577
2002-09-20T00:00:00Z
P5875
P6179
1075175976